生物材料增强的生物活性剂有效地阻断癌症的脊髓转移
Shixian Liu1, Zhonghan Wang2, Qi Wei3
1Department of Orthopedics, The Second Hospital of Jilin University, 218 Ziqiang Street, Changchun 130041, PR China; Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, 5625 Renmin Street, Changchun 130022, PR China.
概括
先进的生物材料增强了脊髓转移的治疗方法,这是常见的癌症并发症. 这些材料提高了药物输送和有效性,为骨转移患者提供了新的希望.
科学领域:
- 生物材料科学 生物材料科学
- 在瘤学瘤学.
- 纳米技术纳米技术
背景情况:
- 脊髓转移在癌症患者中很常见 (20%-40%),导致疼痛和神经问题.
- 目前脊髓转移的治疗方法有限,有缓解作用,往往缺乏特异性.
- 生物活性剂看起来有前途,但面临着诸如不良准,副作用和耐药性等挑战.
研究的目的:
- 审查用于增强脊髓转移治疗的生物材料的发展.
- 探索生物材料如何提高脊髓转移的各种疗法的疗效.
- 预测脊髓转移的生物材料介导治疗的未来研究方向.
主要方法:
- 关于生物材料和脊髓转移疗法研究的文献综述.
- 分析生物材料在化疗,光疗和脊髓转移的高温治疗中的应用.
- 综合有关药物递送系统和刺激响应释放机制的信息.
主要成果:
- 生物材料显著改善瘤向和脊髓转移的治疗剂的输送.
- 先进的生物材料使生物活性剂的持续和刺激反应释放成为可能.
- 生物材料可以增强化疗,光疗,磁热和组合疗法的有效性.
结论:
- 生物材料对于克服当前脊髓转移治疗的局限性至关重要.
- 生物材料介导疗法提供了更好的特异性,减少了副作用,并克服了耐药性.
- 未来的研究应该专注于用于高级脊髓转移管理的新生物材料设计.
相关概念视频
Mesenchymal Stem Cells
4.8K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.8K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K


